sellWeak cluster of 310b5-1 plan
Christina Rossi sold $229k of BPMC
CHIEF OPERATING OFFICER at Blueprint Medicines Corp. 2,274 shares at an average of $100.51, traded May 19, 2025, filed May 21, 2025.
Warning score
28Value
$229k
2,274 shares
Holdings after
64,718
-3% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +20RoleCOO
- +13Trade size$229k at market
- 0Share of holdings soldSold 3.4% of holdings
- +15Cluster3 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-25-013941, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 19, 2025 | SOpen-market sale Common Stock10b5-1 | -804 | $100.14 | $81k | 66,188 | May 21, 2025 |
| May 19, 2025 | SOpen-market sale Common Stock10b5-1 | -1,413 | $100.67 | $142k | 64,775 | May 21, 2025 |
| May 19, 2025 | SOpen-market sale Common Stock10b5-1 | -57 | $101.72 | $5,798 | 64,718 | May 21, 2025 |
Related signals
Other insiders at Blueprint Medicines Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 34Weak | Blueprint Medicines Corp | Percy H. Carter CHIEF SCIENTIFIC OFFICER | $135k 1,051 shares | -2% | |
| 39Weak | Blueprint Medicines Corp | Christina Rossi CHIEF OPERATING OFFICER | $150k 1,172 shares | -2% | |
| 38Weak | Blueprint Medicines Corp | Percy H. Carter CHIEF SCIENTIFIC OFFICER | $340k 2,659 shares | -5% | |
| 13Weak | Blueprint Medicines Corp | Jeffrey W. Albers director | $506k 5,000 shares | -3% | |
| 7Weak | Blueprint Medicines Corp | Ariel Hurley PRINCIPAL ACCOUNTING OFFICER | $284k 2,752 shares | -14% | |
| 21Weak | Blueprint Medicines Corp | Christina Rossi CHIEF OPERATING OFFICER | $231k 2,274 shares | -3% | |
| 25Weak | Blueprint Medicines Corp | Kate Haviland CHIEF EXECUTIVE OFFICER | $216k 2,498 shares | -1% | |
| 27Weak | Blueprint Medicines Corp | Christina Rossi CHIEF OPERATING OFFICER | $216k 2,274 shares | -3% | |
| 48Moderate | Blueprint Medicines Corp | Jeffrey W. Albers director | $512k 5,766 shares | -4% | |
| 15Weak | Blueprint Medicines Corp | Jeffrey W. Albers director | $659k 7,500 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.